Valuation: Acarix AB

Market Cap 30Cr 3.15Cr 2.73Cr 2.54Cr 2.33Cr 4.41Cr 300.18Cr 4.48Cr 12Cr 149.4Cr 12Cr 12Cr 499.17Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 30Cr 3.15Cr 2.73Cr 2.54Cr 2.33Cr 4.41Cr 300.18Cr 4.48Cr 12Cr 149.4Cr 12Cr 12Cr 499.17Cr EV / Sales 2026 *
15.7x
EV / Sales 2027 * 4.31x
Free-Float
83.24%
Yield 2026 *
-
Yield 2027 * -
1 day+1.61%
1 week+2.23%
1 month-0.98%
3 months-6.67%
6 months+5.44%
Current year-5.97%
1 week 0.24
Extreme 0.2395
0.26
1 month 0.23
Extreme 0.232
0.26
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.42
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.6
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.61%+2.23%-41.19%-49.60% 3.14Cr
-1.89%-1.36%+16.24%-41.91% 1.57TCr
+4.47%+7.46%+1.25%+106.27% 177.35Cr
+1.21%+4.49%-27.15%-80.80% 114.36Cr
-1.73%+2.33%-38.79%+13.42% 98Cr
+1.29%+7.31%-46.81%-52.67% 65Cr
+0.93%+7.41%-45.76%-53.34% 54Cr
+1.08%+2.47%+53.71%-51.95% 47Cr
-0.81%+1.33%-53.54%-62.03% 37Cr
-0.81%+5.14%-15.69%-32.94% 37Cr
Average +0.53%+2.50%-19.77%-30.56% 220.39Cr
Weighted average by Cap. -0.94%-0.19%+5.93%-30.56%

Financials

2026 *2027 *
Net sales 1.91Cr 20.09L 17.41L 16.21L 14.89L 28.15L 19Cr 28.6L 75.01L 9.54Cr 75.43L 73.77L 32Cr 6.95Cr 73.09L 63.35L 58.98L 54.19L 1.02Cr 70Cr 1.04Cr 2.73Cr 35Cr 2.74Cr 2.68Cr 115.93Cr
Net income -2.89Cr -30.39L -26.34L -24.53L -22.53L -42.6L -29Cr -43.27L -1.14Cr -14Cr -1.14Cr -1.12Cr -48Cr 24L 3L 2L 2L 2L 4L 2.41Cr 4L 9L 1.2Cr 9L 9L 4Cr
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
31/26/31 SEK 0.2520 +1.61% 4,91,404
30/26/30 SEK 0.2480 -1.00% 4,32,272
29/26/29 SEK 0.2505 -0.40% 8,86,675
28/26/28 SEK 0.2515 +1.82% 10,69,871
27/26/27 SEK 0.2470 +0.20% 4,37,653

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock